Emcure Plans for Expansion and New Acquisitions with Upcoming IPO
Emcure Pharmaceuticals has been planning to expand its business as the upcoming initial public offering (IPO) will give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions.
IPO | 29/06/2024 | By Aishwarya | 469
Mumbai-based Blue Jet Healthcare files for IPO
The public issue with a face value of Rs 2 per equity share is a complete offer-for-sale (OFS) of up to 21,683,178 equity shares by Promoter and selling shareholders
IPO | 05/09/2022 | By Sudeep Soparkar | 486
Concord Biotech files DRHP for IPO
Concord Biotech is the leading global developer and manufacturer of select fermentation-based APIs across immunosuppressants and oncology
IPO | 16/08/2022 | By Sudeep Soparkar | 476
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy